Hematología

2007

1. Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 trial

   Journal of Clinical Oncology, Vol. 25, Núm. 1, pp. 16-24

2. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: Results from a multicenter European study (MCMDM-1VWD)

   Journal of Thrombosis and Haemostasis, Vol. 5, Núm. 4, pp. 715-721

3. Lessons about recombinant activated factor VII. Ten years since its registration for use in hemophilia with inhibitor

   Medicina Clinica, Vol. 129, Núm. 10, pp. 382-386

4. Mutational analysis of the von Willebrand factor gene in type 1 von Willebrand disease using conformation sensitive gel electrophoresis: A comparison of fluorescent and manual techniques

   Haematologica, Vol. 92, Núm. 4, pp. 550-553

5. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

   Blood, Vol. 109, Núm. 1, pp. 112-121

6. Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis

   Leukemia, Vol. 21, Núm. 1, pp. 143-150

7. Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis

   International Journal of Hematology, Vol. 86, Núm. 1, pp. 33-36

8. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia

   European Journal of Haematology, Vol. 78, Núm. 2, pp. 102-110

9. Sirolimus as Part of Immunosuppressive Therapy for Refractory Chronic Graft-versus-Host Disease

   Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 6, pp. 701-706

10. Tho adjusted International Prognostic Index and β-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma

    Haematologica, Vol. 92, Núm. 8, pp. 1067-1074

11. Update on viral infections in immunocompromised patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 2-11

12. Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients

    Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 12, pp. 1448-1454

13. von Willebrand factor/factor VIII concentrate (Haemate® P) dosing based on pharmacokinetics: A prospective multicenter trial in elective surgery

    Journal of Thrombosis and Haemostasis, Vol. 5, Núm. 7, pp. 1420-1430